Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative. Here's why.
Okta shares continued their fall Monday after the company said client files had been accessed by an unknown hacker, the latest attempt involving the company.
The "bond vigilantes are coming back" as investors continue to sell amid the prospect of a growing fiscal deficit, according to UBS Asset Management's Kevin Zhao.
The flight operated by an Alaska Airlines subsidiary bound for San Francisco diverted to Portland after an off-duty pilot tried to shut down the engines.
Generation Z is leading the "soft saving" trend, a new financial approach that prioritizes personal growth and mental wellness over aggressive saving goals.
Tsingtao Brewery said Monday that an investigation was currently underway after a viral video surfaced showing a staff member urinating into one of its tanks.
Micron is the only company making memory in the U.S. That's made it a target in the chip war with China, but it's still building the country's biggest chip fab.